Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2009, p. 3126-3130, Vol. 53, No. 7
0066-4804/09/$08.00+0 doi:10.1128/AAC.01353-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
,
University of Manitoba, Winnipeg, Manitoba, Canada,1 Alberta Provincial Public Health Laboratory, Calgary, Alberta, Canada,2 National Microbiology Laboratory, Winnipeg, Manitoba, Canada,3 University of Alberta, Edmonton, Alberta, Canada,4 University of Calgary, Calgary, Alberta, Canada5
Received 9 October 2008/ Returned for modification 3 November 2008/ Accepted 29 March 2009
A total of 142 cefoxitin-resistant Escherichia coli isolates from water sources were collected across Canada. Multidrug resistance was observed in 65/142 (45.8%) isolates. The blaCMY-2 gene was identified in 110/142 (77.5%) isolates. Sequencing of the chromosomal ampC promoter region showed mutations from the wild type, previously shown to hyperproduce AmpC. CMY-2-producing plasmids predominantly belonged to replicon groups I1-I
, A/C, and K/B. The majority of the E. coli isolates belonged to the nonvirulent phylogenetic groups A and B1.
Published ahead of print on 27 April 2009.
Supplemental material for this article may be found at http://aac.asm.org/.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»